⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Mingdu (Zhejiang) Digital Intelligence Technology Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Mingdu (Zhejiang) Digital Intelligence Technology Co., Ltd. (often referred to as Mingdu Tech) is a Chinese technology company specializing in digital transformation solutions for the pharmaceutical and life sciences industries. The company provides a comprehensive suite of software and hardware solutions covering the entire drug life cycle, including R&D (Mingdu Science Platform), quality management (QMS), manufacturing execution systems (MES), and intelligent warehousing/logistics (WMS/WCS).
By integrating AI, digital twins, and automation, Mingdu Tech aims to help pharmaceutical companies improve compliance with GxP and FDA 21 CFR Part 11 standards, reduce operational costs, and increase production efficiency. The company is a key player in the Chinese pharmaceutical digitalization market, supporting drug makers in streamlining their research, production, and supply chain processes.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Pharmaceutical Software & Informatics
SIZE & FINANCIALS
Employees:51-200
Revenue:$1M-$10M
Founded:2017
Ownership:private
Status:operating
FUNDING
Stage:Series Unknown
Total Raised:$25.4M
0
CORPORATE STRUCTURE
Subsidiaries:Mingdu Zhiyun (Zhejiang) Technology Co., Ltd.
Key Partnerships:HeYuan Bio (supported their CAR-T product approval)
COMPETITION
Position:Challenger
LEADERSHIP
Key Executives:
Andy Ong (Wang Xiaoxu) - CEO
LINKS
Website:mingdutech.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Mingdu (Zhejiang) Digital Intelligence Technology Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.